Grow your business safely with ABEL PHARMA

All the information you need about ABEL PHARMA to develop and secure your business in France

A HOME > CORPORATES > ABEL PHARMA > BALANCE SHEET ( 2022-11-04)

THE LIST OF BALANCE SHEET : ABEL PHARMA

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2022-11-04 Public 2021-12-31 Complete
2022-03-10 Public 2020-12-31 Simplified
2020-10-01 Public 2019-12-31 Simplified
2018-12-14 Public 2018-06-30 Simplified
NameABEL PHARMA
Siren838681195
Closing2021-12-31
Registry code 4302
Registration number B2022/004757
Management number2018D00090
Activity code 6420Z
Closing date n-12020-12-31
Duration Fiscal year 12
Duration Fiscal year n-112
Filing date2022-11-04
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address43250 SAINTE-FLORINE
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
BB Receivables related to investments 243 683.00 243 683.00 243 683.00
BJ TOTAL (I) 443 633.00 443 633.00 443 633.00
CF Cash and cash equivalents 204.00 204.00 204.00
CJ TOTAL (II) 204.00 204.00 204.00
CO Grand total (0 to V) 443 837.00 443 837.00 443 837.00
CU Other investments 199 950.00 199 950.00 199 950.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 5 000.00 5 000.00 5 000.00
DH Retained earnings -6 966.00 -7 511.00 -6 966.00
DI RESULTS FOR THE YEAR (Profit or Loss) 810.00 545.00 810.00
DL TOTAL (I) -1 156.00 -1 966.00 -1 156.00
DV Miscellaneous Loans and Financial Debts (4) 442 927.00 442 927.00 442 927.00
DX Trade payables and related accounts 2 066.00 1 698.00 2 066.00
EC TOTAL (IV) 444 993.00 444 625.00 444 993.00
EE Grand total (I to V) 443 837.00 442 659.00 443 837.00
EI Including equity loans 442 927.00 442 927.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
FW Other purchases and external expenses 2 008.00
GF Total Operating Expenses (II) 2 008.00
GG - OPERATING RESULT (I - II) -2 008.00
GJ Financial income from other securities and fixed asset receivables 2 818.00
GP Total financial income (V) 2 818.00
GV - FINANCIAL INCOME (V - VI) 2 818.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) 810.00
4 - Income statement (continued)Amount year NAmount year N-1
HL TOTAL REVENUE (I + III + V + VII) 2 818.00 2 809.00 2 818.00
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 2 008.00 2 264.00 2 008.00
HN PROFIT OR LOSS (Total revenue - Total expenses) 810.00 545.00 810.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 440 815.00 2 818.00 440 815.00
I3 DECREASES Total Financial Fixed Assets 443 633.00
I4 DECREASES Grand Total 443 633.00
LQ ACQUISITIONS Total Financial Fixed Assets 440 815.00 2 818.00 440 815.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8B Suppliers and Related Accounts 2 066.00 2 066.00 2 066.00
UL Receivables related to investments 243 683.00 243 683.00 243 683.00
VI Group and Associates 442 927.00 442 927.00 442 927.00
VT TOTAL – STATEMENT OF RECEIVABLES 243 683.00 243 683.00 243 683.00
VY TOTAL – STATEMENT OF LIABILITIES 444 993.00 444 993.00 444 993.00

all companies in France

Complete and comprehensive database.